XML 181 R127.htm IDEA: XBRL DOCUMENT v3.10.0.1
Quarterly Financial Data (Unaudited) (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Selected Quarterly Financial Information [Abstract]                      
Product Revenues $ 3,526.3 $ 3,439.0 $ 3,356.5 $ 3,131.1 $ 3,307.0 $ 3,077.8 $ 3,078.4 $ 2,810.7 $ 13,452.9 $ 12,273.9 $ 11,448.8
Gross Profit [1] 3,037.8 2,978.2 2,935.5 2,685.1 2,797.8 2,707.8 2,712.2 2,426.1 11,636.6 10,643.9  
Net income 944.9 1,442.9 915.0 1,171.2 (166.3) 1,226.1 862.8 747.5 4,474.0 2,670.1 3,695.7
Net income attributable to Biogen Idec Inc $ 946.8 $ 1,444.4 $ 866.6 $ 1,172.9 $ (297.4) $ 1,226.1 $ 862.8 $ 747.6 $ 4,430.7 $ 2,539.1 $ 3,702.8
Basic earnings per share attributable to Biogen Inc. $ 4.74 $ 7.17 $ 4.18 $ 5.55 $ (1.41) $ 5.80 $ 4.07 $ 3.47 $ 21.63 $ 11.94 $ 16.96
Diluted earnings per share attributable to Biogen Inc. $ 4.73 $ 7.15 $ 4.18 $ 5.54 $ (1.40) $ 5.79 $ 4.07 $ 3.46 $ 21.58 $ 11.92 $ 16.93
Basic earnings per share attributable to Biogen Inc. 199.8 201.4 207.1 211.4 211.5 211.4 211.9 215.6 204.9 212.6 218.4
Diluted earnings per share attributable to Biogen Inc. 200.3 201.9 207.3 211.7 212.0 211.8 212.2 215.9 205.3 213.0 218.8
Revenues from anti-cd20 therapeutic programs                      
Selected Quarterly Financial Information [Abstract]                      
Product Revenues $ 534.9 $ 511.7 $ 490.4 $ 443.2 $ 415.0 $ 406.5 $ 397.1 $ 340.6 $ 1,980.2 $ 1,559.2 $ 1,314.5
Other revenue                      
Selected Quarterly Financial Information [Abstract]                      
Product Revenues 165.7 147.2 108.6 164.4 179.6 48.8 41.6 90.0 585.9 360.0 316.4
Product, net                      
Selected Quarterly Financial Information [Abstract]                      
Product Revenues $ 2,825.7 $ 2,780.1 $ 2,757.5 $ 2,523.5 $ 2,712.4 $ 2,622.5 $ 2,639.7 $ 2,380.1 $ 10,886.8 $ 10,354.7 $ 9,817.9
[1] (1) Gross profit is calculated as total revenues less cost of sales, excluding amortization and impairment of acquired intangible assets.